The United States is on track to match or exceed last year’s measles total before the summer is over. According to the CDC, 2,231 confirmed measles cases have been recorded so far in 2026, driven by 32 separate outbreaks that account for 93 percent of all infections. That figure already rivals the 2,289 cases tallied for the entire calendar year of 2025, which the CDC’s own epidemiologists called the largest annual total since 1992. Three states, South Carolina, Utah, and Pennsylvania, have absorbed the bulk of the damage, and the pattern points to a common thread: pockets of low vaccination coverage that allow a highly contagious virus to spread fast once it arrives.
Concentrated outbreaks are driving the national count
A handful of large, geographically concentrated outbreaks explain most of the headline number. South Carolina’s Department of Public Health documented 997 measles cases in its 2025 cluster centered around Spartanburg County, making that single event one of the largest in any state in more than three decades. The outbreak stretched well into the current year’s response timeline and consumed enormous local health department resources as schools, churches, and child care centers grappled with exclusion policies and emergency vaccination drives.
Utah has become the second major hotspot. The state’s Department of Health and Human Services reports 507 residents diagnosed with measles in 2026 to date, with contact tracing and pop-up vaccination clinics still active across multiple local health jurisdictions. These cases span several counties but are concentrated in areas where childhood immunization rates had been slipping prior to the outbreak. Pennsylvania, meanwhile, has identified 84 statewide cases this year, with 72 of those concentrated in the Lancaster-Lebanon region, according to the Shapiro administration’s outbreak response announcement, which detailed school-based clinics and outreach to under-immunized communities.
What ties these outbreaks together is not geography or broad demographic categories but vaccination gaps at the county and community level. Measles requires roughly 95 percent population immunity to prevent sustained transmission, a threshold known as herd immunity. When MMR coverage drops below that line, even a single imported case can trigger chains of infection that last for months. A CDC MMWR report on the 2025 New Mexico outbreak found that most cases occurred in individuals who were unvaccinated or whose vaccination status was unknown, reinforcing the pattern visible in South Carolina, Utah, and Pennsylvania.
Low-coverage counties and the 70 percent question
A straightforward hypothesis follows from the outbreak data: counties where MMR vaccination rates fall below 92 percent will account for at least 70 percent of outbreak-associated cases once the CDC releases geocoded data for 2026. The evidence available so far is consistent with that threshold. Every major 2026 cluster has emerged in communities already flagged for below-average childhood immunization rates, and 93 percent of this year’s cases are outbreak-associated rather than isolated importations, according to the CDC’s national surveillance dashboard.
The hypothesis cannot be confirmed yet because the national dataset does not publish county-level MMR coverage rates matched to individual case locations. State dashboards in Utah and South Carolina break cases down by local health jurisdiction, but they do not release the corresponding vaccination denominators at the same geographic resolution. Without that crosswalk, analysts can only infer the relationship between coverage and outbreak size from aggregate figures and occasional school-level reports. Until the CDC or state agencies publish that linkage, the precise share of cases attributable to sub-92 percent coverage zones remains an estimate, not a confirmed statistic.
Still, the directional evidence is strong. The CDC’s mid-April 2025 national update recorded 800 cases by April 17 of that year, a pace that accelerated sharply through the summer and fall as outbreaks took root in undervaccinated communities. The acceleration tracked with places where exemption rates had been climbing for years and where local health officials had already warned of growing vulnerability. The same dynamic appears to be repeating in 2026, with Utah and Pennsylvania absorbing sustained transmission chains rather than isolated travel-linked cases that fizzle out after a handful of infections.
Conflicting year-end totals and data gaps
One source of confusion in the public record involves the final 2025 case count itself. The CDC’s tracker lists 2,289 confirmed cases for the full year. The BMJ, drawing on CDC data as of December 30, 2025, reported 2,065 confirmed infections. The gap likely reflects late-reported cases added after the BMJ’s cutoff date, but neither source explains the discrepancy directly. For readers tracking the trajectory, the difference matters because it changes the baseline against which 2026’s total is compared. Using the higher CDC figure, 2026 has nearly matched last year’s total with roughly six months still to go. Using the BMJ’s number, the current year has already exceeded it.
Several other data gaps limit the public’s ability to assess the full scope of the crisis. State dashboards in Utah and South Carolina do not release individual-level outcome data such as hospitalization rates, intensive care admissions, or complication breakdowns by age group. Without that information, it is difficult to quantify how many cases involve pneumonia, encephalitis, or other severe consequences, and how those risks are distributed between vaccinated and unvaccinated patients. Nor is there a single public source that provides complete importation-source sequencing or travel-linked case counts for the full 2025–2026 period, leaving open questions about how often the virus is being reintroduced versus spreading within communities.
These blind spots have practical implications. Local officials trying to justify stricter school-entry requirements or targeted vaccination campaigns often face skepticism from residents who want to know how dangerous the current strain is and whether most severe cases are occurring in their own communities. In the absence of detailed, timely data, advocates must rely on historical averages and anecdotal reports from clinicians, which can be easier to dismiss as alarmist or unrepresentative. Clearer, more granular reporting on outcomes and transmission patterns would not only aid researchers but also help the public weigh the trade-offs of policy responses.
Policy responses and the road ahead
Even with incomplete data, the contours of an effective response are clear. Raising MMR coverage in low-uptake pockets remains the single most important lever for preventing additional outbreaks. That means not only enforcing existing school immunization requirements but also addressing the logistical and informational barriers that keep some families from vaccinating on schedule. Extended clinic hours, mobile vaccination units, and partnerships with trusted community organizations can help reach residents who are not opposed to vaccines but have fallen behind.
At the same time, public health agencies are grappling with a hardened core of vaccine refusal. In some of the hardest-hit counties, exemption rates have climbed well beyond state averages, driven by organized misinformation campaigns and longstanding distrust of government institutions. Countering that trend will require sustained investment in communication strategies that go beyond one-off press conferences: training local clinicians to answer common concerns, elevating voices from within communities that have experienced outbreaks firsthand, and ensuring that official messages are consistent across agencies and political administrations.
Nationally, the 2026 measles surge is testing the resilience of a system still recovering from the strains of the COVID-19 pandemic. Contact tracing teams built for respiratory viruses have been repurposed, school nurses are once again on the front lines of outbreak detection, and hospitals are revisiting isolation protocols for highly contagious diseases that many clinicians had never seen in their careers. How the country responds over the next several months-whether it can close coverage gaps, improve data transparency, and rebuild trust-will determine not only the final case count for this year but also whether measles remains a recurring threat or returns to the margins of the American disease landscape.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
